How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

16 June 2020
Efforts to enhance the quality of life of people living with HIV must include a strong focus on mental health and wellbeing 
More
News
01 June 2020
HIV Outcomes is delighted to invite you to join a webinar organised on the Health Policy Platform to discuss the key learnings from The Lancet HIV Series on HIV Outcomes: Beyond Viral Suppression, and explore their policy implications for the ...
More
02 April 2020
People living with HIV face discrimination in society and in healthcare systems – following Zero Discrimination Day (1 March), HIV Outcomes draws policy makers' attention to the concrete actions that they can ...
More
Filters
Initiative Partners
  • Aids Action Europe
  • AFEW International
  • East Europe and Central Asia Union of PLWH
  • European AIDS Treatment Group
  • Gilead
  • ViiV Healthcare
Observer Members
  • European AIDS Clinical Society
  • European Centre for Disease Prevention and Control (ECDC)
  • Fast-track Cities
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.